Drug-off Criteria in Patients with Hepatocellular Carcinoma who Achieved Clinical Complete Response after Combination Treatment with Immunotherapy and Locoregional Therapy

被引:3
|
作者
Kudo, Masatoshi [1 ,2 ]
机构
[1] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, Liver Canc, Osakasayama, Japan
[2] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, 337-2 Ohno Higashi, Osakasayama, Osaka 5898511, Japan
关键词
hepatocellular carcinoma; systemic therapy; locoregional therapy; clinical complete response; drug-off criteria; CONTRAST-ENHANCED ULTRASOUND; ATEZOLIZUMAB PLUS BEVACIZUMAB; RADIOFREQUENCY ABLATION; LIVER RESECTION; VEIN INVASION; SORAFENIB; ULTRASONOGRAPHY; LENVATINIB; SONOGRAPHY; MANAGEMENT;
D O I
10.1159/000532023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:289 / 296
页数:8
相关论文
共 50 条
  • [1] Complete Response to Locoregional Therapy Plus Immunotherapy for Hepatocellular Carcinoma
    Chiang, Chi Leung
    Chan, Kenneth Sik Kwan
    Chiu, Keith Wan Hang
    Lee, Francis Ann Shing
    Chen, Wenqi
    Wong, Natalie Sean Man
    Ho, Ryan Lok Man
    Lee, Venus Wan Yan
    Man, Kwan
    Kong, Feng Ming
    Chan, Albert Chi Yan
    [J]. JAMA ONCOLOGY, 2024,
  • [2] Imaging After Locoregional Therapy for Hepatocellular Carcinoma with Emphasis on LIRADS Treatment Response Assessment Criteria
    Bajaj, Gitanjali
    Sundaram, Karthik
    Jambhekar, Kedar
    Ram, Roopa
    [J]. SEMINARS IN ULTRASOUND CT AND MRI, 2021, 42 (04) : 318 - 331
  • [3] Evaluation of Hepatocellular Carcinoma Treatment Response After Locoregional Therapy
    Kampalath, Rony
    Tran-Harding, Karen
    Do, Richard K. G.
    Mendiratta-Lala, Mishal
    Yaghmai, Vahid
    [J]. MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2021, 29 (03) : 389 - 403
  • [4] The immune response of hepatocellular carcinoma after locoregional and systemic therapies: The available combination option for immunotherapy
    Duan, Yuxin
    Zhang, Hua
    Tan, Tao
    Ye, Wentao
    Yin, Kunli
    Yu, Yanxi
    Kang, Meiqing
    Yang, Jian
    Liao, Rui
    [J]. BIOSCIENCE TRENDS, 2023, 17 (06) : 427 - 444
  • [5] Clinical course of patients with hepatocellular carcinoma who experienced radiologic complete response after radioembolization
    Moon, Sungmo
    Kim, Gyoung Min
    Won, Jong Yun
    Kwon, Joon Ho
    Park, Juil
    Han, Kichang
    Kim, Man-Deuk
    Kim, Hyung Cheol
    Kim, Dong Kyu
    Choi, Jin Young
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [6] Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy
    Park, Jung Gil
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2015, 21 (03) : 287 - 294
  • [7] Characteristics of 18 patients with hepatocellular carcinoma who obtained a complete response after treatment with sorafenib
    Shiba, Satoshi
    Okusaka, Takuji
    Ikeda, Masafumi
    Saito, Hidetsugu
    Ichida, Takafumi
    [J]. HEPATOLOGY RESEARCH, 2014, 44 (13) : 1268 - 1276
  • [8] Pretreatment clinical stage predicts locoregional recurrence in patients with esophageal cancer who achieved a complete clinical response to chemoradiotherapy
    Liw, Pei-Xuan
    Wen, Yu-Wen
    Tsai, Chang-Yo
    Chang, Hsien-Kun
    Tseng, Chen-Kan
    Hung, Tsung-Min
    Chao, Yin-Kai
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (05): : 2233 - +
  • [9] Reproducibility of LI-RADS treatment response algorithm for hepatocellular carcinoma after locoregional therapy
    Razek, A. A. K. Abdel
    El-Serougy, L. G.
    Saleh, G. A.
    Shabana, W.
    Abd El-Wahab, R.
    [J]. DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2020, 101 (09) : 547 - 553
  • [10] METASTATIC BREAST CANCER PATIENTS WHO ACHIEVED CLINICAL COMPLETE RESPONSE AFTER MULTIDISCIPLINARY THERAPY: CLINICAL FEATURES FROM A SINGLE INSTITUTION
    Takuwa, Haruko
    Tsuji, Wakako
    Yotsumoto, Fumiaki
    [J]. BREAST, 2017, 36 : S63 - S63